This document contains a fact sheet that discusses the use of extended-release naltrexone, a relatively new FDA-approved medication for opioid and alcohol use disorders. This resource analyzes the literature surrounding the drug, as it presents a growing support of its feasibility and effectiveness of among the criminal justice populations. The document highlights the drug as an effective tool to discourage program violations and promote successful outcomes for their participants.
Extended-Release Naltrexone Fact Sheet
by wpengine / Friday, 05 May 2017 / Published in Uncategorized